UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.32B |
| 2 |
Elevance Health
ELV
|
+$282M |
| 3 |
Warner Bros
WBD
|
+$173M |
| 4 |
Visa
V
|
+$167M |
| 5 |
AbbVie
ABBV
|
+$143M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Automatic Data Processing
ADP
|
+$490M |
| 2 |
Amazon
AMZN
|
+$350M |
| 3 |
Microsoft
MSFT
|
+$253M |
| 4 |
Baidu
BIDU
|
+$219M |
| 5 |
TC Energy
TRP
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.54% |
| 2 | Healthcare | 15.22% |
| 3 | Financials | 12.07% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Communication Services | 8.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BBBY
2151
DELISTED
Bed Bath & Beyond Inc
BBBY
| $692K | ﹤0.01% |
139,328
+7,369
| +6% | +$85.8K |
|
2152
Clarus
CLAR
$143M
| $692K | ﹤0.01% |
36,462
+21,308
| +141% | +$445K |
|
2153
GoPro
GPRO
$126M
| $691K | ﹤0.01% |
124,865
-2,369
| -2% | -$17.3K |
|
2154
Bank First Corp
BFC
$1.7B
| $690K | ﹤0.01% |
9,104
| – | – |
|
2155
PAR Technology
PAR
$735M
| $687K | ﹤0.01% |
18,312
+46
| +0.3% | +$1.65K |
|
2156
Cytek Biosciences
CTKB
$546M
| $686K | ﹤0.01% |
+63,957
| New | +$637K |
|
2157
Veru
VERU
$37.4M
| $686K | ﹤0.01% |
6,072
+39
| +0.6% | +$4.53K |
|
2158
Nano X Imaging
NNOX
$73.8M
| $686K | ﹤0.01% |
60,702
+26,067
| +75% | +$271K |
|
|
BRY
2159
DELISTED
Berry Corp
BRY
| $682K | ﹤0.01% |
89,448
+9,400
| +12% | +$99.3K |
|
2160
First Financial Corp
THFF
$969M
| $680K | ﹤0.01% |
15,288
+2,542
| +20% | +$111K |
|
|
NPTN
2161
DELISTED
NEOPHOTONICS CORP
NPTN
| $679K | ﹤0.01% |
43,178
-1,294
| -3% | -$19.8K |
|
|
VMEO
2162
DELISTED
Vimeo
VMEO
| $675K | ﹤0.01% |
112,168
-96,664
| -46% | -$877K |
|
|
BRSP
2163
BrightSpire Capital
BRSP
$648M
| $675K | ﹤0.01% |
89,410
-3,155
| -3% | -$26.7K |
|
2164
Vuzix
VUZI
$224M
| $673K | ﹤0.01% |
94,816
+18,176
| +24% | +$107K |
|
|
TRST
2165
Trustco Bank Corp NY
TRST
$938M
| $673K | ﹤0.01% |
21,809
| – | – |
|
|
SRDX
2166
DELISTED
Surmodics
SRDX
| $670K | ﹤0.01% |
17,992
| – | – |
|
|
TRTX
2167
TPG RE Finance Trust
TRTX
$618M
| $667K | ﹤0.01% |
74,059
+15,551
| +27% | +$163K |
|
2168
CEVA Inc
CEVA
$1.08B
| $665K | ﹤0.01% |
19,811
| – | – |
|
|
DCPH
2169
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $664K | ﹤0.01% |
50,511
+5,837
| +13% | +$64.4K |
|
|
LAND
2170
Gladstone Land Corp
LAND
$360M
| $662K | ﹤0.01% |
29,869
| – | – |
|
2171
Theravance Biopharma
TBPH
$877M
| $656K | ﹤0.01% |
72,418
-2,345
| -3% | -$21.6K |
|
2172
Vanda Pharmaceuticals
VNDA
$302M
| $656K | ﹤0.01% |
60,150
| – | – |
|
|
NNDM
2173
Nano Dimension
NNDM
$343M
| $656K | ﹤0.01% |
208,793
+5,991
| +3% | +$17.8K |
|
2174
Horizon Bancorp
HBNC
$1.04B
| $655K | ﹤0.01% |
37,616
+5,712
| +18% | +$102K |
|
|
HSII
2175
DELISTED
Heidrick & Struggles
HSII
| $655K | ﹤0.01% |
20,236
+861
| +4% | +$29.6K |
|
Similar funds
UBS AM's Q2 2022 Portfolio in Review
As of Q2 2022, UBS AM held 2,854 positions worth $191B, down 18% from $233B the previous quarter. Its ten largest holdings account for 22% of the portfolio.
UBS AM's Q2 2022 filing shows 130 new, 1,168 increased, 1,130 reduced and 164 closed positions. Its largest new stake was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M. The largest sale was Automatic Data Processing, an estimated $490M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q2 2022 buy was Vanguard Russell 1000 ETF: 543,239 shares worth $93.3M.
- UBS AM added most to Apple in Q2 2022, an estimated $1.32B increase.
- UBS AM's biggest Q2 2022 reduction was Automatic Data Processing, cutting an estimated $490M.
- UBS AM fully exited TC Energy in Q2 2022, selling an estimated $214M.
- UBS AM's ten largest holdings make up 22% of its $191B portfolio in Q2 2022.
- UBS AM opened 130 new positions and closed 164 in Q2 2022.
- UBS AM's portfolio value fell 18% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q2 2022, filed 12 Aug 2022.